GlassScriptPhysician profile
Reut Moyal
NPI 1205123197
$742.44
in general payments reported to CMS, 2019-2025
14 companies · $43.86 in 2025
The $43.86 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $62.02 · 2021: $49.83 · 2022: $128 · 2023: $40.80 · 2024: $49.66 · 2025: $43.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $228.84 | 2019-2022 | |
| Therapeuticsmd, INC. | $104.42 | 2019-2020 | |
| Organon LLC | $102.32 | 2022-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $70.20 | 2019-2020 | |
| Becton, Dickinson and Company | $49.66 | 2024 | Channel Drain |
| Mayne Pharma Commercial LLC | $27.26 | 2022 | |
| Avion Pharmaceuticals | $26.35 | 2019-2021 | |
| Roche Diagnostics Corporation | $23.05 | 2019 | |
| Coopersurgical, INC. | $22.75 | 2019 | |
| Medline Industries LP | $20.61 | 2025 | |
| Agile Therapeutics, INC. | $18.89 | 2022 | |
| Exeltis, USA INC. | $17.21 | 2019 | |
| Allergan, INC. | $16.18 | 2019 | |
| Millicent US INC | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reut Moyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.